Journal of Veterinary Medicine and Animal Health
Subscribe to JVMAH
Full Name*
Email Address*

Article Number - 605E82D46695


Vol.6(9), pp. 245-250 , September 2014
DOI: 10.5897/JVMAH2011.028
ISSN: 2141-2529



Full Length Research Paper

Decreased level of serum paraoxonase (PON) activity in dogs with dilated cardiomyopathy (DCM)



Mahadesh Prasad AJ*
  • Mahadesh Prasad AJ*
  • Department of Microbiology, Comprehensive Cancer Center, University of Pennsylvania Medical School 201E Johnson Pavilion, 3610 Hamilton Walk Philadelphia.
  • Google Scholar
Monika Krueger
  • Monika Krueger
  • Institute of Bacteriology and Mycology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany.
  • Google Scholar
Maxi Krueger
  • Maxi Krueger
  • Institute of Bacteriology and Mycology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany.
  • Google Scholar







 Received: 06 July 2011  Accepted: 26 July 2014  Published: 30 September 2014

Copyright © 2014 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Serum Paraoxonase (PON1) is a high-density lipoprotein associated esterase capable of hydrolyzing numerous organophosphates and protects low-density lipoprotein against peroxidation. PON1 is believed to play a crucial role in the prevention of cardiovascular disease in animals and PON1 activity has been shown to be low after myocardial infarction, liver disease and during oxidative stress. Here in this article we demonstrated that PON1 level is significantly lowered during the dilated cardiomyopathy (DCM) in dogs.  This investigation was carried out on 208 canine serum samples. The serum PON/arylestrase activity was measured in 84 healthy dogs and 124 dogs with dilated cardiomyopathy (DCM) of varying severity. Since heart failure is characterized by oxidative stress, inflammation, deficiency in metabolic substrates and lack of blood supply to heart. Decreased PON activity was significantly observed in advanced stages of DCM.

 

Key words: DCM, Paraoxonase, Phenyl acetate, High-density lipoprotein, NYHA-classification.

Prasad AJM, Kemparaju K, Elizabeth A. Frank and Cletus J. M. D'Souza (2009). Purification of human serum paraoxonase: A simple and rapid method. Afr. J. Biochem. Res. 3(4):125-129.
 
Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ (1997). Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol. 79:1426-1430.
Crossref
 
Aviram M, Maor I, Keidar S (1995). Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem. Biophys. Res. Commun. 216:501-513.
Crossref
 
Aviram M, Rosenblat M (2008). Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases. Methods Mol. Biol. 477:259-76.
Crossref
 
Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1581-1590.
Crossref
 
Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999). Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26(7-8):892-904.
Crossref
 
Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000). Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. Circulation 101:2510-2517.
Crossref
 
Azarsiz E, Kayikcioglu M, Payzin S, Sözmen EY (2003). PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. Int. J. Cardiol. 91:43-51.
Crossref
 
Bonagura JD (1983). M-Mode echocardiography: basic principles. Vet. Clin. North Am. Small Anim. Pract. 13(2):299-319.
Pubmed
 

Burton KP, McCord JM, Ghai G (1984). Myocardial alterations due to free-radical generation. Am. J. Physiol. 246:776-783.

Pubmed

 
Bionaz M, Trevisi E, Calamari L, Librandi F, Ferrari A, Bertoni G (2007). Plasma paraoxonase, health, inflammatory conditions and liver function in transition dairy cows. J. Dairy Sci. 90(4):170-176.
Crossref
 
Canales A, Sanchez-Muniz FJ (2003). Paraoxonase, something more than an enzyme? Med. Clin. 121(14):537-548.
Crossref
 
Chetboul VT, Nicolle A, sampederano CC, Gouni V, pouchelon JL, Lefebvre HP, Concordet D (2005). Effects of animal position and number of repeated measurements on selected two-dimensional and M-mode echocardiographic variables in healthy dogs." J. Am. Vet. Med. Assoc. 227(5):743-747.
Crossref
 
Dhalla AK, Hill MF, Singal PK (1996). Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28:506-514.
Crossref
 
Feingold K, Memon RA, Moser AH, Grunfeld C (1998). Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139(2):307-315.
Crossref
 
Förstermann U (2010). Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459(6):923-939.
Crossref
 
Fox P, Moise NS (1998). Primary Myocardial disease in dogs. Text Book of Canine and feline cardiology. pp. 582-617.
 
Fox P (1989). Myocardial disease textbook of Veterinary internal medicine. P 1097.
 
Gan KN, Smolen A, Eckerson HW (1991). Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab. Dispos. 19:100-106.
PMid:1673382
 
Genest J Jr, McNamara JR, Salem DN, Ordovas JM, Jenner JL, Millar JS, Silberman SR, Wilson PF, Schaefer EJ (1992). Lipoprotein cholesterol, apolipoproteins A-I and B, and Lipoprotein (a) in men with premature coronary artery disease. J. Am. Coll. Cardiol. 19:782-802.
Crossref
 
Goldhaber JI, Ji S, Lamp ST (1989). Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle. J. Clin. Invest. 83:1800-1809.
Crossref
 
Granér M, James RW, Kahri J, Nieminen MS, Syvänne M, Taskinen MR (2006). Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease. J. Am. Coll. Cardiol. 47:2429-2435.
Crossref
 
Griendling KK, Sorescu D, Ushio-Fukai M (2000). NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:494-501.
Crossref
 
Guerra L, Cerbai E, Gessi S, Borea PA, Mugello A (1996). The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Br. J. Pharmacol. 118:1278-1284.
Crossref
 
Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE(1991). Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30:10141-9.
Crossref
 
Hill MF, Singal PK (1997). Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96:2414-2420.
Crossref
 
Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE (2002). Vitamin C and E Intake is associated with increasesed paraoxoanase activity. Arterioscler Thromb. Vasc. Biol. 22(8):1329-33.
Crossref
 
Katsuramaki T, Hirata K, Kimura Y, Nagayama M, Meguro M, Kimura H, Honma T, Furuhata T, Hideki U, Hata F, Mukaiya M (2002). Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy. Wound Repair Regen. 10:77-8.
Crossref
 
Keith M, Geranmayegan A, Sole MJ (1998). Increased oxidative stress in patients with congestive heart failure. J. Am. Coll. Cardiol. 31:1352-1356.
Crossref
 
Kittleson MK (1998). Primary myocardial disease. Small animal cardiovascular medicine. Elsevier Health.
 
Mackness MI, Durrington PN, Ayub A, Mackness B (1999). Low serum paraoxonase: a risk factor for atherosclerotic disease? Chem. Biol. Interact 119(120):389-397.
Crossref
 
Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E (2001) Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype? Atrerioscler. Thromb. Vasc. Biol. 21:1451-1457.
Crossref
 
Mak S, Newton GE (2001). The Oxidative Stress Hypothesis of Congestive Heart Failure. Chest 120:2035-2046.
Crossref
 
Mallat Z, Philip I, Lebret M (1998). Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97:1536-1539.
Crossref
 

Monnet EO, Salman M, Boon J (1995). Idiopathic dilated cardiomyopathy in dogs: Survival and prognostic indicators. J. Vet. Med. 9(1):12-17.

Pubmed

 
The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little, Brown & Co; 253-256
 
Oda MN, Bielicki TT, Ho T, Berger EM, Rubin T, Forte M (2001). Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochem. Biophys. Res. Commun. 290:921-927.
Crossref
 

Schrier GM, Hess ML (1988). Quantitative identification of superoxide anion as a negative inotropic species. Am. J. Physiol. 255:138-143.

Pubmed

 
Sisson DD, Thomas WP and Keene BW (2000) Primary Myocardial disease in the dogs. In text book of veterinary internal medicine. S.J.E. E.C Feldam. Philadelphia. WB Saunders Co. pp. 874-895.
 
Sisson DT, WP (1995). Myocardial diseases. Textbook of Veterinary internal medicine. WB Saunders Co. pp. 995-1005.
 
Thomas WP (1984). Two dimensional, real-time echocardiography in the dog: technique and validation. Vet. Radiol. 2:50-64.
Crossref
 
Thomas WG, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, Moses BL (1993). Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology American College of Veterinary Internal Medicine." J. Vet. Int. Med. 7(4):247-252.
Crossref
 
Turk R, Juretic D, Geres D, Turk N, Rekic B, Simeon-Rudolf V, Svetina A (2004). Serum Paraoxonase activity and lipid parameters in early postpartum period of dairy cows. Res. Vet. Sci. 76:57-61.
Crossref
 
Turk RD, Juretic D, Geres N, Turk B, Rekic V, Simeon-Rudolf M, Rebic B, Svetina A (2005). Serum Paraoxonase activity in dairy cows during pregnancy. Res. Vet. Sci. 79:15-18.
Crossref
 
Turk RD, Juretic D, Geres A, Svetina N, Turk N, Flegar-Mestric Z (2007). Influence of Oxidative stress and metabolic adaptation on PON1 activity and MDA levels in Transition dairy cows . Anim. Reprod. Sci. 108(1-2):98-106.
Crossref
 
Tsutsui H, Kinugawa S, Matsushima S (2008). Oxidative stress and mitochondrial DNA damage in heart failure. Cir. J. 72:31-37.
Crossref
 
Watson AD, Berliner JA, Hama SY (1995). Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low-density lipoprotein. J. Clin. Invest. 96:2882-2891.
Crossref
 
Xie XM, Zhao SP (2002). Congestive heart failure and paraoxonase. 27(2):157-158.

 


APA Mahadesh, P.A.J., Krueger, M., Krueger, M. (2014). Decreased level of serum paraoxonase (PON) activity in dogs with dilated cardiomyopathy (DCM). Journal of Veterinary Medicine and Animal Health, 6(9), 245-250.
Chicago Mahadesh Prasad AJ , Monika Krueger, Maxi Krueger . "Decreased level of serum paraoxonase (PON) activity in dogs with dilated cardiomyopathy (DCM)." Journal of Veterinary Medicine and Animal Health 6, no. 9 (2014): 245-250.
MLA Mahadesh Prasad AJ , Monika Krueger, Maxi Krueger . "Decreased level of serum paraoxonase (PON) activity in dogs with dilated cardiomyopathy (DCM)." Journal of Veterinary Medicine and Animal Health 6.9 (2014): 245-250.
   
DOI 10.5897/JVMAH2011.028
URL http://academicjournals.org/journal/JVMAH/article-abstract/605E82D46695

Subscription Form